Council on the Kidney in Cardiovascular Disease (KCVD)
Message from the Chair
Welcome to the Council on the Kidney in Cardiovascular Disease (KCVD). Our Council strives to prevent and reduce cardiovascular morbidity and mortality through advocacy for education and research on the role of the kidney in hypertension, heart, and vascular diseases. The whole of the AHA is committed to advocacy and research to improve cardiovascular health, and we participate in that goal through our involvement with the scientific councils. Chronic kidney disease is a major risk factor for cardiovascular disease and death, but through the work of the AHA and this council, we can further promote awareness of the importance of the kidney in cardiovascular health and disease, support research on the origin of kidney-related cardiovascular disease, and support the career development of the next generation of diverse scientists who conduct basic, translational and clinical research to advance the treatment and care of patients with kidney and cardiovascular diseases.
Thu H. Le, MD, FAHA
Chair, Council on the Kidney in Cardiovascular Disease
Science News
KCVD Award History (2017–2024)
Connections Newsletter
Scientific Sessions 2024
Scientific Sessions: November 16–18, 2024McCormick Place Convention Center | Chicago, Illinois
AHA Professional Members are Difference Makers
Current AHA Research Grant and Funding Opportunities
Hypertension
Mark Your Calendars for Hypertension 2025
September 4–7, 2025Marriott Baltimore Waterfront | Baltimore, Maryland